PD-1 blockade increased intra-tumoural proliferating (Ki67+) CD8+ T cells in melanoma [7], with responders additionally displaying a lower overall richness and a greater clonality, namely a higher number of expanded clones, after treatment, with similar results described in peripheral blood in the context of lung cancer [30]. The gene discussed is CD8A; the disease is melanoma.